N 343 2.5 (Glyburide 2.5 mg)
Pill with imprint N 343 2.5 is Orange, Round and has been identified as Glyburide 2.5 mg. It is supplied by Teva Pharmaceuticals USA.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for N 343 2.5







Glyburide
- Imprint
- N 343 2.5
- Strength
- 2.5 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
FD&C Yellow No. 6,
aluminum oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00093-8343 | Teva Pharmaceuticals USA, Inc. |
51079-0872 | UDL Laboratories Inc. |
42291-0316 | AvKare, Inc. |
35356-0360 | Lake Erie Medical and Surgical Supply (repackager) |
55289-0606 | PDRX Pharmaceuticals Inc. (repackager) |
More about glyburide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: sulfonylureas
Consumer resources
- Other brands
- DiaBeta, Micronase, Glycron, Glynase PresTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.